Home › Funds › Blue Owl Capital Holdings LP › PYXS
Blue Owl Capital Holdings LP position in PYXS
PYXIS ONCOLOGY INC · Health Care
Blue Owl Capital Holdings LP reported holding 1,000,000 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 0.44% of its reported portfolio and ranking #29 among its reported holdings. Blue Owl Capital Holdings LP has disclosed PYXS holdings in 3 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Blue Owl Capital Holdings LP's PYXS position evolved
Blue Owl Capital Holdings LP first disclosed a stake in PYXS in Q2 2024 at 1,046,025 shares (US$3.5M). The position peaked in Q3 2024 at 1,126,025 shares, worth US$4.1M. Across 3 filings, Blue Owl Capital Holdings LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,000,000 shares valued at US$2.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 1.05M | $3.46M | New |
| Q3 2024 | 1.13M | $4.13M | Add |
| Q3 2026 | 1.00M | $2.33M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PYXS and 13F data
PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 31 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Laurion Capital Management LP (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PYXS
- GordonMD Global Investments LP 10.02M sh · $30.17M · Q2 2026
- PFIZER INC 7.03M sh · $20.11M · Q3 2026
- Laurion Capital Management LP 4.99M sh · $11.63M · Q3 2026
- Palo Alto Investors LP 864.28K sh · $2.60M · Q2 2026
- Atle Fund Management AB 663.77K sh · $1.55M · Q3 2026
- Decheng Capital LLC 326.81K sh · $983.70K · Q2 2026
- Monashee Investment Management LLC 229.31K sh · $534.29K · Q3 2026
More on Blue Owl Capital Holdings LP
FAQ
How long has Blue Owl Capital Holdings LP held PYXS?
Blue Owl Capital Holdings LP has disclosed PYXS holdings in 3 of the last 10 reported quarters, going back to Q2 2024.
What is Blue Owl Capital Holdings LP's current position in PYXS?
As of Q3 2026, Blue Owl Capital Holdings LP holds 1.00M shares of PYXS (PYXIS ONCOLOGY INC), valued at $2.33M, representing 0.44% of its reported portfolio and ranking #29.
Has Blue Owl Capital Holdings LP been buying or selling PYXS?
In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP newly opened its position in PYXS. The position peaked in Q3 2024 at 1.13M shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Laurion Capital Management LP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.